BrainStorm Cell Therapeutics
BCLI
#10403
Rank
S$8.65 M
Marketcap
S$0.78
Share price
0.83%
Change (1 day)
-62.97%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Total debt

Total debt on the balance sheet as of June 2025 : S$0.74 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's total debt is S$0.74 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

BrainStorm Cell Therapeutics - Total debt on balance sheet (from 2002 to 2025)

Total debt by year

Year Total debt Change
2024-12-31S$0.97 M-41.88%
2023-12-31S$1.68 M-69.31%
2022-12-31S$5.48 M-20.09%
2021-12-31S$6.86 M-28.08%
2020-12-31S$9.54 M199.32%
2019-12-31S$3.18 M
2018-12-31N/A
2010-12-31S$0.17 M-66.03%
2009-12-31S$0.51 M-18.01%
2008-12-31S$0.63 M-71.43%
2007-12-31S$2.21 M28.43%
2006-12-31S$1.72 M
2006-03-31S$0.8 M
2004-03-31S$0.05 M39.72%
2003-03-31S$0.03 M98.33%
2002-03-31S$0.01 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Gilead Sciences
GILD
S$32.34 B 4,322,430.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
S$1.55 B 207,326.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
S$0.14 B 19,568.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$8.54 B 1,142,031.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
S$59.35 M 7,832.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA